CRISM Therapeutics

CRISM Therapeutics Corp to continue pioneering R&D at PHTA following listing on the London Stock Exchange

11 June 2024 -- Birmingham, UK -- CRISM Therapeutics Corporation a UK-based pharmaceutical company focused on improving the clinical performance of cancer treatments for solid tumours, has raised £2.0m to fund clinical trials and further development following its listing, via a reverse takeover, on the AIM Market of the London Stock Exchange. Extruded Pharmaceuticals Ltd...
Kingston Chambers, PO Box 173, Road Town Tortola, British Virgin Islands